Literature DB >> 16386015

Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature.

Nicola Giordano1, Alessandra Amendola, Panayotis Papakostas, Fiorenza Cipolli, Vita Maria Agate, Emilio Battisti, Bruna Marchi, Ranuccio Nuti.   

Abstract

HCV chronic liver disease can be associated with a plethora of immune and autoimmune perturbations and many authors claim that HCV chronic infection can play an important role in the pathogenesis of these disorders. To compare our experience with literature reports, we performed a retrospective study on the case histories of 265 patients with HCV chronic liver disease, evaluating the type and prevalence of the associated immune and autoimmune manifestations. We found that the patients with HCV chronic liver disease can present arthromyalgias (7.1% of the patients), Sjörgen's syndrome (5.2%), thyroiditis (4.1%), rheumatoid arthritis (2.2%), autoimmune thrombocytopenia (2.6%), mixed cryoglobulinemia (1.5%), autoimmune anemia (0.3%) and oral lichen planus (0.3%). We claim that HCV liver infection is able to induce immune and autoimmune perturbations, without playing a significant role in the pathogenesis of a well-defined disorder.

Entities:  

Mesh:

Year:  2005        PMID: 16386015

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  8 in total

1.  Sicca complex among Egyptian patients with chronic hepatitis C virus infection.

Authors:  Zeinab Nawito; Amr Amin; Sohier Abu El-Fadl; Khaled Abu El Einen
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

2.  Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Authors:  Elizabeth Y Chiao; Eric A Engels; Jennifer R Kramer; Kenneth Pietz; Louise Henderson; Thomas P Giordano; Ola Landgren
Journal:  Arch Intern Med       Date:  2009-02-23

Review 3.  Immunological HCV-associated thrombocytopenia: short review.

Authors:  Dimitrios Dimitroulis; Serena Valsami; Paraskevas Stamopoulos; Gregory Kouraklis
Journal:  Clin Dev Immunol       Date:  2012-07-10

4.  HCV Infection Alters Salivary Gland Histology and Saliva Composition.

Authors:  J O Maldonado; M E Beach; Y Wang; P Perez; H Yin; E Pelayo; S Fowler; I Alevizos; M Grisius; A N Baer; B Walitt; V De Giorgi; H J Alter; B M Warner; J A Chiorini
Journal:  J Dent Res       Date:  2022-01-20       Impact factor: 8.924

5.  Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.

Authors:  Nishant Poddar; Jen C Wang
Journal:  Hematol Rep       Date:  2013-01-25

Review 6.  Xerostomia due to systemic disease: a review of 20 conditions and mechanisms.

Authors:  H Mortazavi; M Baharvand; A Movahhedian; M Mohammadi; A Khodadoustan
Journal:  Ann Med Health Sci Res       Date:  2014-07

Review 7.  Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection.

Authors:  Shiksha Kedia; Vijaya Raj Bhatt; Sandeep Kumar Rajan; Pavan Kumar Tandra; Radwa A El Behery; Mojtaba Akhtari
Journal:  Int J Prev Med       Date:  2014-12

8.  A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan.

Authors:  Norikane Miki; Sachie Inoue; Hidetoshi Shibahara; Kenji Kurazono; Rodolphe Perard; Ryosuke Tateishi
Journal:  JGH Open       Date:  2021-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.